Ilyang PharmaceuticalLtd 관리
관리 기준 확인 0/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Dong-Yeon Kim
최고 경영자
n/a
총 보상
| CEO 급여 비율 | n/a |
| CEO 임기 | no data |
| CEO 소유권 | 0.05% |
| 경영진 평균 재임 기간 | 데이터 없음 |
| 이사회 평균 재임 기간 | 데이터 없음 |
최근 관리 업데이트
Recent updates
Is Ilyang PharmaceuticalLtd (KRX:007570) A Risky Investment?
Apr 04
Should You Be Adding Ilyang PharmaceuticalLtd (KRX:007570) To Your Watchlist Today?
Mar 14Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely
Mar 14Declining Stock and Decent Financials: Is The Market Wrong About Ilyang Pharmaceutical Co.,Ltd (KRX:007570)?
Feb 22Did Business Growth Power Ilyang PharmaceuticalLtd's (KRX:007570) Share Price Gain of 159%?
Feb 01Is Ilyang Pharmaceutical Co.,Ltd's (KRX:007570) Shareholder Ownership Skewed Towards Insiders?
Jan 11
Here's Why Ilyang PharmaceuticalLtd (KRX:007570) Can Manage Its Debt Responsibly
Dec 24A Look At The Intrinsic Value Of Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
Dec 06Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 18CEO
Dong-Yeon Kim (74 yo)
no data
테뉴어
Mr. Dong-Yeon Kim serves as the Chief Executive Officer and President of Ilyang Pharmaceutical Co., Ltd. Mr. Kim served as Head of Laboratory at Ilyang Pharmaceutical Co., Ltd. He serves as a Director of I...